Dr Reddys Laboratories Ltd Share Price Today - Live Blog for January 16, 2026

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.85% in its share price, and it currently trades at 1176.40 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.85% drop, and it's now trading at 1176.40 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Dr Reddys Laboratories Ltd plunged by -0.84%, leaving investors concerned. At this moment, the stock can be acquired at 1176.50, but investors are assessing whether this is a temporary dip or a long-term trend.

After a notable 0.06% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1187.20. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

Dr Reddys Laboratories Ltd's stock has surged by 0.32%, and it is currently trading at 1190.30. Additionally, the stock maintains a PE ratio of 17.2600, while the industry PE is 33.0081.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.78%. At this moment, it's actively trading at 1195.70, presenting an enticing opportunity for those in the market.

Following a noteworthy 0.22% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1189.10. When it comes to valuation, this stock has a PE ratio of 17.2600, with the industry PE ratio at 33.0081.